22 May 2013
Keywords: roferon-a, save, sight, swiss, major, hoffmann-la, roche
Article | 16 March 1992
Swiss major Hoffmann-La Roche's Roferon-A (recombinant interferon
alfa-2a) may prove to be a useful treatment for certain elderly patients
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 March 1992
21 May 2013
© 2013 thepharmaletter.com